| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/18/2009 | US7576258 Transgenic transchromosomal rodents for making human antibodies |
| 08/18/2009 | US7576197 SiRNA targeting KRAS |
| 08/18/2009 | US7576196 siRNA targeting transducin (beta)-like 3 (TBL3) |
| 08/18/2009 | US7576195 Endosperm-specific plant promoter for cultivated plants |
| 08/18/2009 | US7576194 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection; for immunodiagnosis and immunoprophylaxis |
| 08/18/2009 | US7576193 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 08/18/2009 | US7576192 Rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors |
| 08/18/2009 | US7576184 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity |
| 08/18/2009 | US7576180 Opioid growth factor receptors |
| 08/18/2009 | US7576179 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 08/18/2009 | US7576178 DADD, death activator death domain protein |
| 08/18/2009 | US7576176 Neisseria meningitidis antigens and compositions |
| 08/18/2009 | US7576065 Administering the neurotrophic factor and the inhibitor into the lateral ventricles or ventricular wall to induce neuronal production in the brain and spinal cord of the subject;. suppressing astrocyte generation; neurodegenerative diseases |
| 08/18/2009 | US7576058 Method for importing biologically active molecules into cells |
| 08/18/2009 | US7575935 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 08/18/2009 | US7575928 Nucleotide sequences isolated via suppression subtractive hybridization for use as tool in detection of cell proliferative disorders |
| 08/18/2009 | US7575924 Expression vector for use in the treatment and prevention of cancer |
| 08/18/2009 | US7575923 CD19xCD3 specific polypeptides and uses thereof |
| 08/18/2009 | US7575922 Polypeptide and gene encoding the same |
| 08/18/2009 | US7575920 Intestinal trefoil factor genetic expression vectors; nucleotide sequences; overexpression and secretion of Pichia genes; N-terminal fusion sequence, a protease cleavage site purification; wound healing agents; lesion repair; urogenital, gastrointestinal, respiratory system disorders; vision defects |
| 08/18/2009 | US7575919 Recombinant vector; overexpresses an adenovirus death protein (ADP), is replication-restricted to neoplastic cells expressing telomerase |
| 08/18/2009 | US7575918 GENETIC ENGINEERED nucleic acid, VECTOR CODING ANTISENSE AGENTS; FOR USE IN KILLING PREFERENTIAL TARGET CELLS OR MICRORGANISMS; biodrugs as antitumor agent, bactericides, anticarcinogenic agent; target on antibiotic resistant bacteria, drug-resistant cancer cells |
| 08/18/2009 | US7575917 DNA constructs and methods to enhance the production of commercially viable transgenic plants |
| 08/18/2009 | US7575916 Nucleic acid molecule encoding a MHC class I peptide epitope from the human 5T4 tumor-associated antigen and vector comprising the nucleic acid molecule |
| 08/18/2009 | US7575913 Genetic engineered genome and nucleotide seuences encoding cellular envelope polypeptides in volved in metabolism, replication, virulence, antisense and ribozyme peptides; vectors; microorganism detection kits for medical diagnosis; bactericides; vaccines |
| 08/18/2009 | US7575910 Method for producing L-fuculose and method for producing L-fucose |
| 08/18/2009 | US7575904 Polymer grafting by polysaccharide synthases |
| 08/18/2009 | US7575902 Universal bases for nucleic acid analyses, methods for using universal bases, and kits comprising universal bases |
| 08/18/2009 | US7575901 Method for producing nucleotide by fermentation |
| 08/18/2009 | US7575900 Non-reducing saccharide-forming enzyme, trehalose-releasing enzyme, and process for producing saccharides using the enzymes |
| 08/18/2009 | US7575898 Comprises nucleotide sequences coding zein and therapeutic proteins for expression in plants; bioreactors; gene therapy |
| 08/18/2009 | US7575894 Human recombinant beta-interferon with improved solubility |
| 08/18/2009 | US7575893 Producing high yield of monoclonal antibody in culture; for use in treatment of cell proliferative, inflammatory and nervous system disorders; immunoassay |
| 08/18/2009 | US7575892 Expression vector encoding a triterpene hydroxylase polypeptide |
| 08/18/2009 | US7575891 Process for production of diphtheria toxin |
| 08/18/2009 | US7575885 Tyrosylprotein sulfotransferases and methods of use thereof |
| 08/18/2009 | US7575879 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; bradycardial agents; identification and preparation of vascular endothelial growth factor-E (VEGF-E), a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1 |
| 08/18/2009 | US7575872 An antibody specific for von Willebrand factor specific cleaving enzyme (hereinafter also referred to as ADAMTS-13), which can be obtained from a warm-blooded animal immunized and sensitized with a polypeptide containing a part or the whole of ADAMTS-13 amino acid sequence |
| 08/18/2009 | US7575865 Automatic; genomes; polymerase chain reactions |
| 08/18/2009 | US7575862 Assay systems, kits and methods for detecting microorganisms |
| 08/18/2009 | US7575860 DNA joining method |
| 08/18/2009 | US7575857 which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells; gene therapy |
| 08/18/2009 | US7575766 Tagetes erecta with altered carotenoid compositions and ratios |
| 08/18/2009 | US7575763 Membrane scaffold proteins and tethered membrane proteins |
| 08/18/2009 | US7575753 Relates to a kit for detecting and distinguishing one or more small round structure viruses (hereinafter called "SRSVs") in a specimen; SRSV detection kit comprising all antibodies against SRSV-related virus constituting peptides; human viral gastroenteritis |
| 08/18/2009 | US7575752 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 08/18/2009 | US7575749 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 08/18/2009 | US7575748 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates |
| 08/18/2009 | CA2413156C Expression vectors |
| 08/18/2009 | CA2404616C Use of vegf and homologues to treat neuron disorders |
| 08/18/2009 | CA2365135C Method for amplifying nucleic acid sequence |
| 08/18/2009 | CA2288215C Use of immunomodulating agents |
| 08/18/2009 | CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 08/18/2009 | CA2224150C Use of locally applied dna fragments |
| 08/18/2009 | CA2223691C Tumor- or cell-specific herpes simplex virus replication |
| 08/18/2009 | CA2184841C Recombinant adenovirus coding for glial-derived neurotrophic factor (gdnf) |
| 08/18/2009 | CA2105552C Soluble ligands for cd40 |
| 08/18/2009 | CA2054798C Hcv-specific peptides, agents therefor and the use thereof |
| 08/13/2009 | WO2009100460A1 Systems and methods for measuring the effectiveness of advertising |
| 08/13/2009 | WO2009100433A1 Methods and compositions for plant pest control |
| 08/13/2009 | WO2009100376A2 Modification of antigens while maintaining antibody binding epitopes |
| 08/13/2009 | WO2009100373A1 Treatment of chronic pain with zinc finger proteins |
| 08/13/2009 | WO2009100351A2 Delivery of rnai constructs to oligodendrocytes |
| 08/13/2009 | WO2009100318A1 1b20 pcsk9 antagonists |
| 08/13/2009 | WO2009100297A1 1d05 pcsk9 antagonists |
| 08/13/2009 | WO2009100178A2 New brassica ogura restorer lines with shortened raphanus fragment (srf) |
| 08/13/2009 | WO2009100173A2 Demethylation and inactivation of protein phosphatase 2a |
| 08/13/2009 | WO2009100159A2 Methods of diagnosing and treating parp-mediated diseases |
| 08/13/2009 | WO2009100138A2 Variants of bacillus stearothermophilus alpha-amylase and uses thereof |
| 08/13/2009 | WO2009100127A2 Isolated brca1 peptides and method of use |
| 08/13/2009 | WO2009100040A2 Cell lines expressing gaba receptor and methods using them |
| 08/13/2009 | WO2009100008A2 Genetic methods for speciating campylobacter |
| 08/13/2009 | WO2009099942A2 Chemically modified oligonucleotides and uses thereof |
| 08/13/2009 | WO2009099906A2 Directed evolution of grg31 and grg36 epsp synthase enzymes |
| 08/13/2009 | WO2009099899A2 Promoter, promoter control elements, and combinations, and use thereof |
| 08/13/2009 | WO2009099783A2 High level expression and accumulation of heterologous polypeptide in plant tissue |
| 08/13/2009 | WO2009099749A1 Use of plastid transit peptides derived from glaucocystophytes |
| 08/13/2009 | WO2009099728A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 08/13/2009 | WO2009099481A1 Maize leaf- and stalk-preferred promoter |
| 08/13/2009 | WO2009099378A1 Selection of rna-aptamers as anti-malaria agents |
| 08/13/2009 | WO2009099176A1 Antibody capable of binding specifically to aβ-oligomer, and use thereof |
| 08/13/2009 | WO2009099147A1 Il-1 type ii receptor gene-deficient mutant of mouse |
| 08/13/2009 | WO2009099112A1 Novel dna fragment and use thereof |
| 08/13/2009 | WO2009099073A1 Modified trna containing non-natural nucleotide and use thereof |
| 08/13/2009 | WO2009099044A1 Method of producing lactic acid by continuous fermentation |
| 08/13/2009 | WO2009099037A1 Primer and probe for detecting chlamydophila caviae, as well as a chlamydophila caviae detection method using the same |
| 08/13/2009 | WO2009098998A1 Nucleic acid detection method, and nucleic acid detection kit |
| 08/13/2009 | WO2009098988A1 Sirna detection method |
| 08/13/2009 | WO2009098885A1 Dectin-2 gene-deficient non-human animal |
| 08/13/2009 | WO2009098789A1 Method of detecting pathogenic virus in crustacean by lamp method and reagent kit for detection |
| 08/13/2009 | WO2009098700A1 Siva 3, its preparation and use |
| 08/13/2009 | WO2009098690A2 Novel fer -like protein, pharmaceutical compositions containing it and method for its use |
| 08/13/2009 | WO2009098682A2 Methods and compositions for treatment of mitochondrial disorders |
| 08/13/2009 | WO2009098492A2 Modulation of adenoviral tropism |
| 08/13/2009 | WO2009098464A2 Use of g-rich oligonucleotides for treating neoplastic diseases |
| 08/13/2009 | WO2009098450A2 Methods and compositions |
| 08/13/2009 | WO2009098410A1 Leporipoxvirus-derived vaccine vectors |
| 08/13/2009 | WO2009098290A1 Fto-modified non-human mammal |
| 08/13/2009 | WO2009098284A2 Methods and devices for producing biomolecules |
| 08/13/2009 | WO2009098263A1 Method for the targeted integration of multiple copies of a gene of interest in a yarrowia strain |